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Rheumatic diseaseThe viral determinants of alphavirus-induced rheumatic disease have not been elucidated. We identiﬁed an
RRV strain (DC5692) which, in contrast to the T48 strain, does not induce musculoskeletal inﬂammation in a
mouse model of RRV disease. Substitution of the RRV T48 strain nonstructural protein 1 (nsP1) coding
sequence with that from strain DC5692 generated a virus that was attenuated in vivo despite similar viral
loads in tissues. In contrast, substitution of the T48 PE2 coding regionwith the PE2 coding region fromDC5692
resulted in attenuation in vivo and reduced viral loads in tissues. In gain of virulence experiments, substitution
of the DC5692 strain nsP1 and PE2 coding regions with those from the T48 strain was sufﬁcient to restore full
virulence to the DC5692 strain. These ﬁndings indicate that determinants in both nsP1 and PE2 have critical
and distinct roles in the pathogenesis of RRV-induced musculoskeletal inﬂammatory disease in mice., University of Colorado School
urora, CO 80045, USA. Fax: +1
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Ross River virus (RRV) is a positive-sense, single-stranded RNA
virus in the Alphavirus genus of the family Togaviridae (Powers et al.,
2001). RRV is among a group of related mosquito-transmitted
alphaviruses, which includes chikungunya virus, Mayaro virus,
o'nyong-nyong virus, and others, that typically cause a debilitating
musculoskeletal inﬂammatory disease in humans. These viruses are
an emerging disease threat due to their ability to cause explosive
epidemics. Past epidemics include a 1979-to-1980 epidemic of RRV
disease in the South Paciﬁc that involved more than 60,000 patients
(Harley et al., 2001) and a 1959-to-1962 epidemic of o'nyong-nyong
fever in Africa that involved at least 2 million infections (Williams et al.,
1965). Since 2004, chikungunya virus has caused major epidemics in
multiple countries in the Indian Ocean region with estimates on the
order of 1–6 million cases (Weaver and Reisen, 2010).Clinical manifestations following infection with arthritis/myositis-
associated alphaviruses develop following an incubation period ranging
from2 to 12 days (Harley et al., 2001; Pialoux et al., 2007). The disease is
most commonly characterized by fever, intense pain in the peripheral
joints,myalgias, and an impaired ability to ambulate (Harley et al., 2001;
Pinheiro et al., 1981; Staples et al., 2009). A number of studies indicate
thatmusculoskeletal pain lasts formonths to years in a subset of persons
infected with RRV or CHIKV, however, the cause of these long lasting
symptoms is unclear (Borgherini et al., 2008; Brighton et al., 1983;
Harley et al., 2001; Larrieu et al., 2010; Simon et al., 2007; Sissoko et al.,
2009). There are currently no licensed antivirals or vaccines for any of
the arthritis/myositis-associated alphaviruses. Treatment is limited to
supportive care with analgesics and anti-inﬂammatory drugs (Harley
et al., 2001; Pialoux et al., 2007).
To study the pathogenesis of arthritis/myositis-associated alpha-
viruses, we have developed a mouse model of RRV-induced disease,
based on subcutaneous inoculation of 1000 pfu of the T48 strain of RRV
into the footpad of 3–4 week-old C57BL/6mice, that recapitulatesmany
aspects of thehumandisease (Morrisonet al., 2007, 2008, 2006). Studies
with the RRV mouse model demonstrated that, following a high titer
serum viremia, bone/joint-associated tissues and skeletal muscle tissue
are the primary targets of RRV replication (Morrison et al., 2006). RRV
replication at these sites results in a severe inﬂammatory responsewith
Fig. 1.Multi-step replication analysis. (A) Schematic representations of the genomes of
the T48 strain molecular clone RR64 (white), RRV strain DC5692 (grey), and the
DC5692 molecular clone RR87. (B) Vero cells were inoculated with 0.01 pfu/cell of
RR64, RRV strain DC5692, or RR87. At the times indicated, 100 μl of supernatant was
harvested and virus titers were determined by plaque assay on BHK-21 cell monolayers.
The dashed line indicates the limit of detection. No statistically signiﬁcant differences
were detected.
217H.J. Jupille et al. / Virology 410 (2011) 216–227abundant tissue damage leading to deﬁcits in grip strength and an altered
gait. This model recapitulates many aspects of human RRV and CHIKV
infection, including i) high titer serum viremia in people infected with
RRV or CHIKV (Hoarau et al. 2010; Parola et al., 2006), ii) the detection of
RRV RNA and antigen in human joint tissue (Fraser et al., 1981; Soden
et al., 2000), iii) the detection of CHIKV antigen in quadriceps muscle
biopsies (Ozden et al., 2007), iv) the presence of mononuclear
inﬂammatory inﬁltrates in joints and muscle tissue of RRV or CHIKV
infected patients (Fraser et al., 1981; Hazelton et al., 1985; Hoarau et al.
2010;Ozdenet al., 2007), andv) thedisease signs experiencedby infected
patients. Thus, understanding the host and viral factors that contribute to
pathogenesis in this mouse model may aid the development of therapies
and vaccines to treat or prevent human disease.
A number of studies have identiﬁed genomic regions, genes, or
speciﬁc molecular determinants that contribute to alphavirus neuro-
virulence (Aguilar et al., 2008; Bernard et al., 2000; Davis et al., 1991;
Frolova et al., 2002; Gardner et al., 2009; Glasgow et al., 1994; Grieder
et al., 1995; Kobiler et al., 1999; Powers et al., 2000; Russell et al., 1989;
Santagati et al., 1995; Schoepp and Johnston, 1993; Suthar et al., 2005;
Tucker and Grifﬁn, 1991; Tuittila et al., 2000; White et al., 2001).
However, no studies have identiﬁed viral determinants important for
alphavirus-induced musculoskeletal inﬂammatory disease. Utilizing
our RRV disease model, we report here the identiﬁcation of a murine-
attenuated RRV strain (DC5692). To identify genetic determinants
associated with virulence, chimeric viruses composed of various
portions of the mouse virulent T48 strain and the DC5692 strain were
constructed and analyzed in vitro and in vivo. These studies identiﬁed
critical, yet distinct, roles for determinants encoded in the nonstructural
protein 1 (nsP1) and the PE2 coding regions in the pathogenesis of
RRV-induced musculoskeletal inﬂammatory disease.
Results
RRV strain DC5692 and virus derived from a molecular clone of RRV strain
DC5692 (RR87) replicate like the T48 strain in Vero cells, but do not cause
musculoskeletal inﬂammatory disease in mice
We have developed a mouse model of RRV-induced rheumatic
disease that has been utilized to identify host factors that promote
inﬂammation and damage of musculoskeletal tissues following RRV
infection (Lidbury et al., 2008; Morrison et al., 2007, 2008, 2006; Rulli
et al., 2009). In contrast, the viral genetic determinants of alphavirus-
induced musculoskeletal inﬂammatory disease are unknown. In an
effort to identify such determinants, we ﬁrst sought to identify RRV
strains that were defective for the induction of inﬂammatory disease
in vivo, but which replicated like the virulent RR64 (virus derived from
the molecular clone of the T48 strain) in vitro. This strategy was
adopted to eliminate viruses that may be attenuated in vivo due to
intrinsic replication differences in simple mammalian cell culture
systems. Screening of multiple RRV isolates resulted in the identiﬁ-
cation of one candidate strain (RRV DC5692), which replicated with
similar kinetics to RR64-derived virus in Vero cells (Figs. 1A and B),
but unlike RR64, DC5692 did not cause overt disease signs in infected
mice (Fig. 2A). At 10 dpi, RR64-infectedmice had severe inﬂammation
and tissue damage in musculoskeletal tissues such as the quadriceps
muscles (Fig. 2B). Similar to control mice, mice inoculated with 103 pfu
of RRV DC5692 did not have evidence of inﬂammation or damage of
quadriceps muscle tissue at 10 dpi (Fig. 2B).
The fact that the DC5692 strain showed similar replication to the
T48 strain in Vero cells, but a defect in the induction of virus-induced
disease, suggested that this virus might be a useful tool for identifying
critical viral determinants of T48 strain-induced musculoskeletal
inﬂammatory disease. Therefore, as a ﬁrst step in this process, we
sought to create a full-lengthmolecular clone of DC5692 with the goal
of using this clone to create chimeric viruses with RR64 to map viral
virulence determinants. To establish this system, the completegenome sequence, except the 5′ untranslated region (UTR), of RRV
strain DC5692 was determined (GenBank HM234643) and compared
to the sequence of RR64. This analysis revealed a total of 356
nucleotide differences (96.8% identity) within the coding region of the
genomes (nucleotides 79–11,330). As shown in Table 1, 47 of the 356
nucleotide changes resulted in an amino acid difference. Due to the
existence of only 2 synonymous nucleotide differences within the ﬁrst
200 nucleotides of the nsP1 coding sequence of these two RRV strains,
a molecular clone that encodes nucleotides 272–11,329 of RRV strain
DC5692 (pRR87; Fig. 1A) was constructed as described in Materials
and methods. Infectious virus derived from the molecular clone of
strain DC5692 (RR87) replicated like the biological isolate and RR64 in
Vero cells (Fig. 1B). Furthermore, inoculation of mice with 103 pfu of
RR87 did not result in detectable disease signs or evidence of
inﬂammation of quadriceps muscle tissue (Fig. 2B).
A chimeric virus that encodes the RRV DC5692 3′ UTR in the genetic
background of the T48 strain (RR67) caused disease in mice that was
indistinguishable from RRV T48 (RR64)-induced disease
Sequence analysis revealed a number of differences in the
nucleotide sequences of the RRV DC5692 3′ UTR compared to the 3′
UTR of the T48 strain (Fig. 3A). These differences include a 79
nucleotide deletion within the DC5692 3′ UTR, which eliminates most
of repeat element 2, a 34 bp deletion, which eliminates a large region
of repeat element 3, an 11 nucleotide deletion, and numerous other
nucleotide changes. Thus, the RRV DC5692 strain 3′ UTR (not
including the poly A tail) is 398 nucleotides in length with 2 intact
repeat elements (1 and 4) whereas the 3′ UTR of the T48 strain is 523
nucleotides in length and encodes 4 repeat elements (1–4). To test
whether the 3′ UTR of the T48 strain contributed to virulence in the
mouse model, a chimeric virus encoding the RRV DC5692 strain 3′
Table 1
Amino acid differences of RRV T48 (RR64) and RRV
DC5692.
nsP1 nsP4
S79C T7I
A112S V29A
L224I T89A
C416F V99A
S424N A359V
L463I E399D
nsP2 V438I
R11K V459I
A31T K514N
E116D Capsid
M140T K73Q
T175A N84K
S406T P89S
R464K E3
nsP3 R59G
I192V E2
S330P Y18H
T331M I67M
V362L H94R
V412I R251K
K427T H255Q
A431T E302V
A435del. E1
V461A S120L
K494E V304A
I510V L413M
S518P
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(Fig. 3B). Inoculation of 103 pfu of either RR64 or RR67 resulted in
disease signs (Fig. 3C) and inﬂammation of quadriceps muscles
(Fig. 3D) that were indistinguishable. These data, together with the
data that indicated that the 5′ and 3′ UTRs of the T48 strain were not
sufﬁcient to enhance the virulence of the DC5692 strain (Fig. 2),
suggest that the 3′ UTRs of these RRV strains do not encode major
virulence determinants in this mouse model of inﬂammatory
rheumatic disease.
Chimeric viruses that encode the RRV DC5692 nsP1 coding region in the
T48 strain genetic background are attenuated in vivo
To test whether important virulence determinants of T48 strain-
induced musculoskeletal inﬂammatory disease are encoded in the
nonstructural region of the genome, a panel of chimeric virus cDNAs
was constructed (Fig. 4). Full-length RNAs encoding the parental and
chimeric virus genomes formed plaques with similar efﬁciency after
transfection into BHK-21 cells (Fig. S1A), whereas all of the chimeric
viruses that encode the nsP1 coding region from the DC5692 strain
had a small plaque phenotype on BHK-21 cells compared to RR64
(Fig. S1B). Similar to virus derived from the DC5692 molecular clone,
RR87, inoculation of mice with RR76, which encodes nsP1, nsP2, nsP3,
and the N-terminal portion of nsP4 from the RRV DC5692 strain in the
T48 strain genetic background resulted in severely diminished
inﬂammation of quadricepsmuscle tissue and disease signs compared
to RR64 (Figs. 4A and B; P≤0.05). To further map the determinantsFig. 2. The RRV DC5692 strain and virus derived from a molecular clone of the DC5692
strain (RR87) are attenuated in vivo. (A) Twenty-four-day-old C57BL/6J mice were
inoculatedwith PBS (n=3), or 103 pfu of RR64 (n=4), RRV strain DC5692 (n=5), or the
molecular clone of DC5692, RR87 (n=5) by injection in the left rear footpad. Mice were
scored for the development of disease signs including loss of gripping ability, hind-limb
weakness, and altered gait. Each data point represents the arithmetic mean±standard
deviation (SD). Data was evaluated for statistically signiﬁcant differences by ANOVA
(Pb0.0001) followed by Bonferroni's Multiple Comparison Test. (B) At 10 dpi, mice were
sacriﬁced and perfused with 4% paraformaldehyde. Five micron-thick parafﬁn-embedded
sections generated from quadriceps muscles were stained with H&E. Images are
representative of three mice per group.
Fig. 3. A chimeric virus that encodes the RRV DC5692 3′ UTR in the T48 genetic background (RR67) caused disease in mice that was indistinguishable from RRV T48-induced disease.
(A) Alignment of the 3′ UTR of the RRV strains DC5692 and T48. The underlined TAA (ﬁrst row) is the E1 stop codon. The italicized and underlined sequences are the repeat elements
present in the T48 3′ UTR. (B) Schematic representations of the T48 derived (white) and DC5692 derived (grey) sequence within the genomes of RR64 and RR67. (C) Twenty-four-
day-old C57BL/6J mice were inoculated with 103 pfu of RR64 (n=4), RRV strain DC5692 (n=4), or RR67 (n=4) by injection in the left rear footpad. Mice were scored for the
development of disease signs including loss of gripping ability, hind-limb weakness, and altered gait. Each data point represents the arithmetic mean±SD. No statistically signiﬁcant
differences were detected. (D) At 10 dpi, mice were sacriﬁced and perfused with 4% paraformaldehyde. Five micron-thick parafﬁn-embedded sections generated from quadriceps
muscles were stained with H&E. Images are representative of four mice per group.
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Fig. 4. Chimeric viruses that encode the RRV DC5692 nsP1 coding region in the T48 strain genetic background are attenuated in vivo. (A) Twenty-four-day-old C57BL/6J mice were
inoculated with 103 pfu of RR64, RR76, RR79, RR77, RR94, or RR95 by injection in the left rear footpad. At 10 dpi, mice were sacriﬁced and perfused with 4% paraformaldehyde. Five
micron-thick parafﬁn-embedded sections generated from the quadriceps muscle were stained with H&E. Images are representative of three mice per group. (B) Twenty-four-day-
old C57BL/6J mice were inoculated with 103 pfu of RR64 (n=19), RR76 (n=9), RR77 (n=11), RR79 (n=9), RR94 (n=7), or RR95 (n=3) by injection in the left rear footpad. Mice
were scored for the development of disease signs including loss of gripping ability, hind-limb weakness, and altered gait. Each data point represents the arithmetic mean±standard
error of the mean (SEM). Data are combined from four independent experiments and were evaluated for statistically signiﬁcant differences by ANOVA (Pb0.0001) followed by
Bonferroni's Multiple Comparison Test (see text).
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nsP1–nsP2 (RR79) or nsP3 and the N-terminal portion of nsP4 (RR77)
from RRV DC5692 in the T48 genetic background. As shown in Figs. 4A
and B, while RR77 elicited disease signs identical to the virulent RR64
virus, RR79 was signiﬁcantly attenuated (P≤0.01). Additional
chimeras encoding either nsP1 or nsP2 from the RRV DC5692 strain
in the T48 strain genetic background (RR94 and RR95, respectively)demonstrated that the presence of the nsP1, but not the nsP2, coding
region of the DC5692 strain resulted in diminished inﬂammation in
skeletal muscle tissues and signiﬁcantly less severe disease signs
(Figs. 4A and B; P≤0.001). To investigate whether the attenuated
phenotype of RR94 was due to inefﬁcient processing of the chimeric
P12 protein, we compared nonstructural protein processing kinetics
of the parental viruses, RR64 and RR87, to RR94. As shown in Fig. S2,
221H.J. Jupille et al. / Virology 410 (2011) 216–227no differences in nonstructural protein processing were observed in
vitro. Taken together, these data suggest that a determinant(s) in nsP1
plays a critical role in the pathogenesis of the musculoskeletal
inﬂammatory disease caused by themouse virulent T48 strain (RR64).
Chimeric viruses that encode the RRV DC5692 PE2 coding region in the
T48 genetic background are attenuated in vivo
While the data presented above demonstrated that determinants
within nsP1 are required for the induction of inﬂammatory disease
by the T48 strain (RR64), we also sought to assess the relative
contribution of the viral structural genes to disease. Therefore, a second
panel of chimeric viruses was constructed to test whether important
virulence determinants of T48 strain-induced inﬂammatory disease are
encoded in the structural regionof the genome(Fig. 5). Full-lengthRNAs
encoding these chimeric virus genomes formed plaques with similarFig. 5. Chimeric viruses that encode the RRV DC5692 PE2 coding region in the T48 gene
inoculated with 103 pfu of RR64, RR73, RR78, RR101, RR102, or RR100 by injection in the lef
Five micron-thick parafﬁn-embedded sections generated from quadriceps muscles were stai
old C57BL/6J mice were inoculated with 103 pfu of RR64 (n=10), RR73 (n=7), RR78 (n=
Micewere scored for the development of disease signs including loss of gripping ability, hind-
Data are combined from three independent experiments and were evaluated for statistic
Comparison Test (see text).efﬁciency compared to the T48 strain after transfection into BHK-21
cells (Fig. S1A). Interestingly, similar to the chimeric viruses encoding
nsP1 from theDC5692 strain, all of the chimeric viruses that encode PE2
from the DC5692 strain had a small plaque phenotype on BHK-21 cells
compared to the T48 strain (Fig. S1B). Inoculation of mice with RR73,
which encodes the very C-terminus of E2, 6K, and E1 from the RRV
DC5692 strain in the T48 strain genetic background resulted in
musculoskeletal inﬂammation and disease signs indistinguishable
from those observed following inoculation of RR64 (Fig. 5). In contrast,
inoculation of micewith a chimera that encodes the C-terminal of nsP4,
capsid, E3, and themajority of E2 fromRRVDC5692 (RR78) or a chimera
that encodes E3, E2, 6K, andE1 fromRRVDC5692 (RR101) resulted in an
attenuated phenotype (Figs. 5A and B; P≤0.01). Taken together, these
ﬁndings suggested that an important determinant(s) was located in the
PE2 coding region. To conﬁrm this ﬁnding, two additional chimeras,
RR102 and RR100, were constructed. Inoculation of mice with RR102,tic background are attenuated in vivo. (A) Twenty-four-day-old C57BL/6J mice were
t rear footpad. At 10 dpi, mice were sacriﬁced and perfused with 4% paraformaldehyde.
ned with H&E. Images are representative of three mice per group. (B) Twenty-four-day-
4), RR101 (n=3), RR102 (n=3), or RR100 (n=7) by injection in the left rear footpad.
limbweakness, and altered gait. Each data point represents the arithmetic mean±SEM.
ally signiﬁcant differences by ANOVA (Pb0.0001) followed by Bonferroni's Multiple
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strain genetic background, resulted in musculoskeletal inﬂammation
anddisease signs indistinguishable fromRR64-inoculatedmice (Figs. 5A
and B). Inoculation of mice with RR100, which encodes RRV DC5692 E3
and the majority of E2 in the genetic background of the T48 strain
resulted in an attenuated phenotype (Figs. 5A and B; P≤0.05). Thus, all
chimeras that encode the PE2 coding region of the RRVDC5692 strain in
the T48 strain genetic background (RR78, RR101, and RR100) were
attenuated when inoculated into mice. These ﬁndings suggest that a
determinant(s) in the PE2 coding region also plays a critical role in the
pathogenesis of RRV-induced musculoskeletal inﬂammatory disease.
Attenuating determinants in PE2, but not nsP1, regulate viral tissue titers
in mice
To investigate whether the attenuation of RR94 and RR100
chimeric viruses in vivo was associated with differences in viral loads
in tissues, mice were inoculated with RR64, RR87, RR94, or RR100 and
the amounts of infectious virus present in serum, joint, and skeletal
muscle tissues at 1, 3, and 5 dpi were quantiﬁed by plaque assays
(Fig. 6). The viral loads in tissues of RR87-inoculated mice were
signiﬁcantly lower compared to RR64-inoculated mice at all time
points examined (Fig. 6). Interestingly, the amounts of infectious virus
in tissues of RR94-inoculated mice were similar to the amounts in
tissues of RR64-inoculated mice, suggesting that a determinant(s) in
RRV nsP1 regulates activation of host inﬂammatory responses in
musculoskeletal tissues independent of effects on viral titers in these
tissues (Fig. 6). In contrast, the pattern of tissue titers detected in mice
inoculated with RR100 was very similar to that detected in mice
inoculated with RR87, with the exception of serum titers at 3 dpi
(Fig. 6). At 1 dpi, RR87 and RR100 titers were dramatically lower than
RR64 and RR94 titers in serum, ankle joints, and quadriceps muscles.
Whereas RR64 and RR94 peak viral titers occurred by 1 dpi, RR87 and
RR100 tissue titers reached a lower peak by 3 dpi and then returned to
lower levels by 5 dpi. These ﬁndings indicate that the attenuating
determinant(s) in the RRV DC5692 PE2 coding region regulates
efﬁcient viral replication in tissues.
A chimeric virus that encodes the RRV T48 strain nsP1 and PE2 coding
regions in the RRV DC5692 genetic background caused disease in mice
that was indistinguishable from RRV T48 (RR64)-induced disease
We next constructed a panel of chimeric viruses to test whether
the nsP1 and PE2 coding regions derived from the T48 strain were
sufﬁcient to convert the DC5692 strain, which is highly attenuated in
mice (Fig. 2), into a virus that causes musculoskeletal inﬂammatory
disease (Fig. 7). Each of these chimeric virus genomes had similar RNA
infectivities compared to the T48 strain (Fig. S1A). Inoculation of mice
with RR106, which encodes the T48 nsP1 coding region in the DC5692
strain genetic background (the reciprocal virus to RR94), resulted in
severely diminished inﬂammation of quadriceps muscle tissue and
disease signs compared to RR64 (Figs. 7A and B; P≤0.01). Similarly,
inoculation of mice with RR108, which encodes the T48 PE2 coding
region in the DC5692 strain genetic background (the reciprocal virus
to RR100), resulted in an attenuated disease phenotype (Figs. 7A
and B; P≤0.05). These results indicated that neither the T48 nsP1 nor
PE2 coding regions alone were sufﬁcient to enhance the virulence of
the DC5692 strain to that of the T48 strain. Inoculation of mice with
RR109, which encodes both the T48 nsP1 and PE2 coding regions
in the DC5692 genetic background, resulted in inﬂammation of
musculoskeletal tissue and disease signs indistinguishable from RR64-
inoculated mice (Figs. 7A and B). Interestingly, although neither the
T48 nsP1 (RR106) nor the PE2 coding regions alone (RR108) were
sufﬁcient to reverse the small plaque phenotype of the DC5692 strain
(RR87) on BHK-21 cells, RR109 formed plaques on BHK-21 cells that
were indistinguishable from those formed by the T48 strain (Fig. S1B).These ﬁndings indicate that both the T48 nsP1 and PE2 coding regions
are necessary and sufﬁcient to convert strain DC5692 into a virus that
caused musculoskeletal inﬂammatory disease in mice indistinguish-
able from that caused by the T48 strain.
Discussion
A large number of studies, utilizing mouse models of Sindbis virus
(SINV), Semliki Forest virus (SFV), Eastern equine encephalitis virus
(EEEV), or Venezuelan equine encephalitis virus (VEEV) neuropatho-
genesis, have shed light on the genetic determinants of alphavirus
neurovirulence. In contrast, no studies have identiﬁed viral genetic
determinants that promote alphavirus-induced rheumatic disease.
We identiﬁed a strain of RRV (RRV strain DC5692) that replicates like
the mouse virulent T48 strain (RR64) in Vero cells but fails to initiate
musculoskeletal inﬂammation following inoculation into mice. These
ﬁndings suggested that RRV strain DC5692 could be used to identify
RRV genetic determinants critical for the development of disease in
the mouse model. Thus, we generated a molecular clone of RRV strain
DC5692 and a panel of T48-DC5692 chimeric viruses and used them to
identify speciﬁc genes associated with the musculoskeletal inﬂam-
matory disease.
The 3′ UTRs of alphaviruses encode a number of sequence
elements. These elements include a 19 nucleotide sequence adjacent
to the poly A tail that is highly conserved among alphaviruses and
functions in RNA replication (Strauss and Strauss, 1994). In addition,
alphavirus 3′ UTRs contain 40–60 nucleotide repeat sequence
elements that vary in sequence and length among different alpha-
viruses (Ou et al., 1982). The biologic function of the repeat sequence
elements is unclear, although recent evidence suggests that these
elementsmay regulate viral RNA deadenylation (Garneau et al., 2008).
Alignment of the DC5692 and T48 genome sequences revealed a
number of differences in the 3′ UTRs of these two viruses. Extensive
variability in 3′UTRs among RRV isolates has been previously reported
(Faragher and Dalgarno, 1986), however, whether these differences
impact the development of disease is not known. To test whether the
differences in the 3′ UTRs contributed to pathogenesis in the mouse
model, we generated a chimeric virus that encodes the DC5692 3′UTR
in the T48 strain genetic backbone (RR67). Inoculation of mice with
RR67 resulted in disease indistinguishable from mice inoculated with
the T48 strain, suggesting that the 3′ UTR of the DC5692 strain is not
sufﬁcient to attenuate T48 strain-induced disease in this model of
musculoskeletal inﬂammatory disease. Furthermore, RR87, which is
phenotypically indistinguishable in vitro and in vivo from the DC5692
biological isolate, encodes the complete DC5692 coding region
bracketed by the 5′ and 3′ UTRs of the T48 strain. Our experiments
indicated that replacing the 3′ UTR of the DC5692 strain with the T48
strain 3′ UTR did not result in a gain of virulence.
To investigate whether genes within the nonstructural coding
region of the genome contributed to pathogenesis in the mouse
model, a series of chimeric viruses was constructed and tested in vivo
for their ability to cause disease. From these experiments, we
discovered that substitution of the T48 nsP1coding region with the
nsP1 coding region from strain DC5692, which differ by six amino
acids, generated a virus (RR94) that failed to cause disease in mice. In
contrast to RR94, chimeric viruses encoding DC5692 nsP2, nsP3, or
various portions of nsP4 in the T48 strain genetic background caused
disease like the T48 strain. Interestingly, viral loads of RR94 in serum
and musculoskeletal tissues were indistinguishable from those in
mice inoculatedwith the T48 strain (RR64) from 1 to 5 dpi, suggesting
that a determinant(s) in nsP1 modulates the host inﬂammatory
response independent of effects on RRV tissue titers during the
initiation phase of the inﬂammatory disease in mice.
Alphavirus nsP1 is a replicase protein that functions in viral RNA
replication and viral RNA capping (Strauss and Strauss, 1994). In
studies of temperature sensitive (ts) mutants of SFV and SINV, only
Fig. 6. Attenuating determinants in PE2, but not nsP1, regulate viral tissue titers in mice. Twenty-four-day-old C57BL/6J mice were inoculated with 103 pfu of RR64 (ﬁlled circles),
RR87 (open circles), RR94 (ﬁlled squares), or RR100 (open squares) by injection in the left rear footpad. At 1, 3, and 5 dpi mice (n=3–6) were sacriﬁced, blood was collected via
cardiac puncture, and mice were perfused by intracardial injection with 1X PBS. Tissues were dissected, weighed, and homogenized and the amount of infectious virus present was
quantiﬁed by plaque assay on BHK-21 cells. Dashed lines indicate the limit of detection. *P≤0.05, **P≤0.01, and ***P≤0.001 as determined by ANOVA.
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mutants is speciﬁcally defective inminus-strand synthesis (Lulla et al.,
2008; Wang et al., 1991). In addition, nsP1 encodes guanine-7-
methyltransferase and guanyltransferase activities which are essen-
tial for capping and cap methylation of viral genomic and subgenomic
RNAs (Ahola and Kaariainen, 1995; Ahola et al., 1997; Mi et al., 1989;
Scheidel et al., 1989). The structure of nsP1 is unknown and deletion
studies have failed to deﬁne speciﬁc enzymatic subdomains. However,speciﬁc mutations that affect the binding of enzymatic substrates
have been located in the ﬁrst 310 amino acids of nsP1 (Lulla et al.,
2008). For example, two conserved acidic residues, D62/D88 in RRV
nsP1, are essential for S-adenosyl-L-methionine binding and residues
S23 and V302 may function in GTP binding (Lulla et al., 2008).
Previous studies have identiﬁed determinants within nsP1 critical
for alphavirus neurovirulence. In all alphaviruses, nsP1 contains 1–3
cysteine residues at positions 418–420 (SFV numbering) and the nsP1
Fig. 7. Substitution of the DC5692 strain nsP1 and PE2 coding regions with those from the T48 strain is sufﬁcient to enhance the virulence of the DC5692 strain. (A) Twenty-four-day-
old C57BL/6J mice were inoculated with 103 pfu of RR64, RR106, RR108, or RR109 by injection in the left rear footpad. At 10 dpi, mice were sacriﬁced and perfused with 4%
paraformaldehyde. Five micron-thick parafﬁn-embedded sections generated from quadriceps muscles were stained with H&E. Images are representative of three mice per group.
(B) Twenty-four-day-old C57BL/6J mice were inoculated with 103 pfu of RR64 (n=10), RR106 (n=5), RR108 (n=7), or RR109 (n=9) by injection in the left rear footpad. Mice
were scored for the development of disease signs including loss of gripping ability, hind-limbweakness, and altered gait. Each data point represents the arithmetic mean±SEM. Data
are combined from three independent experiments and were evaluated for statistically signiﬁcant differences by ANOVA (Pb0.0001) followed by Bonferroni's Multiple Comparison
Test (see text).
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palmitoylated at these conserved cysteines (Ahola et al., 2000;
Laakkonen et al., 1996). Mutation of the SFV nsP1 palmitoylation site
(CCC to AAA at position 418 to 420) generated a virus thatwas avirulent
in mice (Ahola et al., 2000). Interestingly, the mouse attenuated RRV
strainDC5692encodes a phenylalanine insteadof a cysteineatRRVnsP1
position 416 (C416F). However, in contrast to the T48-nsP15692 chimera
(RR94), the SFVmutanthaddramatically altered growth in BHK-21 cells
and dramatically reduced tissue titers in mice at all time points
examined (Ahola et al., 2000), suggesting there is a differentmechanism
of attenuation for RR94.
Our studies suggest that nsP1 plays a critical role in the initiation of
musculoskeletal inﬂammation and are the ﬁrst to directly implicate a
nonstructural protein in the pathogenesis of alphavirus-induced
inﬂammatory rheumatic disease. The divergent in vivo phenotypes
of RR64 and RR94, highly inﬂammatory vs. non-inﬂammatory,
respectively, suggest that a speciﬁc determinant(s) within nsP1 of
the T48 strain may promote the severe host inﬂammatory response,
independent of viral titers at the normal sites of inﬂammation.
Comparison of the T48 and RRV DC5692 nsP1 sequences revealed a
total of 36 nucleotide changes. Six of these changes resulted in an
amino acid coding change (S79S, A112S, L224I, C416F, S424N, and
L463I) (Table 1). Future experiments will assess whether one or a
combination of these amino acid changes is responsible for the
attenuated phenotype.
In this study, we also investigated whether determinants within the
structural region of the genome contributed to the pathogenic versus
nonpathogenic phenotypes of the T48 strain and the DC5692 strain in
the mouse model. Our experiments identiﬁed a critical role for a
determinant(s) in the PE2 coding region, as substitution of the T48 PE2coding regionwith that from theDC5692 strain,whichdiffer by 7 amino
acids, resulted in an attenuated phenotype. In contrast to the RR94
chimera, tissue titers inmice inoculatedwithRR100 (which encodes the
DC5692 PE2 coding region in the T48 strain genetic background), were
dramatically altered compared to mice inoculated with the T48 strain.
These ﬁndings support a model in which determinants within PE2 and
nsP1 regulate distinct steps within the pathogenic sequence that leads
to musculoskeletal inﬂammation and disease.
The mechanism(s) by which the DC5692 PE2 protein leads to
attenuation will require further study. PE2 and the mature E2 form of
the protein have a number of roles in the viral life cycle, including
roles in virus attachment and entry, virion assembly, and budding.
In addition, the mature E2 glycoprotein is the major target of
neutralizing antibodies. A number of studies have implicated
determinants in the E2 glycoprotein in alphavirus neurovirulence.
For example, alternating intracranial passage of a laboratory-adapted
SINV in neonatal and weanling mice led to the selection of an SINV
strain with increased neurovirulence (Grifﬁn and Johnson, 1977). A
glutamine to histidine change at E2 position 55, which enhances
binding and entry into neurons as well as virus-induced apoptosis of
neurons, was identiﬁed as the primary determinant associated with
the neurovirulent phenotype (Lee et al., 2002; Tucker et al., 1997). It
will be of interest to test whether the amino acid changes present in
the DC5692 E2 protein regulate RRV binding and entry of speciﬁc cell
types associated with disease, such as connective tissue ﬁbroblasts,
osteoblasts, myoﬁbers, and/or macrophages. In other studies, serial
passaging of SINV or VEEV in BHK-21 cells resulted in attenuating
mutations associated with adaptation to use of heparan sulfate as a
receptor by the acquisition of positively charged amino acid residues
in E2 (Bernard et al., 2000; Davis et al., 1986). It remains to be formally
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heparan sulfate.
To test whether the nsP1 and PE2 coding regions could increase
the virulence of the DC5692 strain, we constructed an additional set of
chimeric viruses. Our results indicated that neither the T48 nsP1 nor
PE2 coding regions alone were sufﬁcient to enhance the virulence of
the DC5692 strain to that of the T48 strain. However, a chimeric virus
that encodes both the T48 strain nsP1 and PE2 coding regions in the
DC5692 genetic background caused disease in mice that was
indistinguishable from that caused by the T48 strain. These ﬁndings
provide further evidence that mutations in nsP1 and PE2 are critical
determinants of RRV-induced musculoskeletal inﬂammatory disease.
In summary, utilizing pathogenic and apathogenic strains of RRV
and a chimeric virus approach, we have identiﬁed critical, yet distinct,
roles for nsP1 and PE2 in the pathogenesis of RRV-induced rheumatic
disease in mice. These are the ﬁrst studies to identify viral gene
regions that promote alphavirus-induced rheumatic disease. Future
studies will investigate the speciﬁc determinants within nsP1 and PE2
that impact disease outcomes and the mechanism(s) by which these
determinants regulate pathogenesis.
Materials and methods
Viruses
The T48 strain of RRVwas isolated from Aedes vigilaxmosquitoes in
Queensland, Australia. Prior to cDNA cloning, the virus was passaged
10 times in sucklingmice followedby twopassages onVero cells. Thus,
this strain may be adapted for enhanced virulence in mice. RRV strain
DC5692 was isolated in 1995 from Aedes camptorhynchusmosquitoes
at Dawesville Cut in the Peel region ofWesternAustralia. The viruswas
passaged 1 time in C6/36 cells, 1 time in Vero cells, and 1 time in BHK-
21 cells prior to cDNA cloning. Trizol reagent (Invitrogen) was added
to an aliquot of infected BHK-21 cell supernatant andRRVDC5692RNA
was puriﬁed using a Mini RNA isolation kit (Invitrogen) according to
the manufacturer's instructions. RNA was reverse-transcribed and
the RRV DC5692 genome was ampliﬁed in a series of overlapping
fragments by PCR using primers based on the T48 strain sequence and
Deep Vent DNA polymerase (NEB). Amplicons were cloned into pCR-
Blunt using the Zero Blunt PCR cloning kit (Invitrogen). Forward and
reverse sequencing of at least 2 independent amplicons per regionwas
performed at the complete genome sequence, except the 5′ UTR, was
determined (GenBank HM234643).
Viral stocks were generated from full-length and chimeric virus
cDNAs as previously described (Morrison et al., 2006). Brieﬂy,
plasmids encoding virus cDNAs were linearized by digestion with
Sac I. 5′-Capped full-length RNA transcripts were generated in vitro
using SP6-speciﬁc mMessage mMachine in vitro transcription kits
(Ambion). Full-length transcripts were electroporated into BHK-21
cells using a Bio-Rad Gene pulser electroporator. Culture supernatants
were harvested at 24 h after electroporation, centrifuged for 20 min at
3000 rpm, aliquoted, and stored at−80 °C. Viral stocks were titrated
by plaque assay on BHK-21 cells.
Construction of virus cDNAs
Plasmids encoding full-length and chimeric viral cDNAs are
designated by the preﬁx “p”. Infectious virus derived from the cDNA
clone does not contain the preﬁx “p”. Plasmid pRR64 (provided by
Richard Kuhn, Purdue University) encodes the full-length cDNA of the
T48 strain of RRV. To generate a chimeric virus cDNA that encodes the
RRV DC5692 3′ UTR in the T48 genetic background, a shuttle vector
(pRR65) was created by religation of pRR64 that had been digested
with Aﬂ II and Psh AI followed by a klenow ﬁll in reaction. This
resulted in a plasmidwith a unique Hind III site at RRV position 11329,
which is at the junction of the E1 gene and the 3′UTR and a unique SacI site at the 3′ end of the RRV poly A tail. The 3′ UTR of RRV DC5692
was PCR ampliﬁed with a 3′ primer that engineered a Sac I restriction
site downstream of the poly A tail. The RRV DC5692 3′ UTR was
inserted into the Hind III–Sac I site of pRR65 to create pRR66. The Xma
I–Sac I fragment of pRR66 was inserted into the Xma I–Sac I site of
pRR64 to generate pRR67 which encodes a chimeric virus genome
composed of the RRV DC5692 3′ UTR in the T48 genetic background.
To generate pRR77, the RRV DC5692 Eag I–XbaI fragment was
inserted into the Eag I–Xba I site of pRR64. To generate plasmids pRR76
and pRR79, the RRV DC5692 BssH II–Eag I fragment was inserted into
the BssH II–Eag I site of pRR77 and pRR64, respectively. To generate
pRR94 and pRR95, pRR64 and pRR79 were digested with Eco RI and
the ~8300 bp fragmentwas gel isolated and religated to generate pRR90
and pRR91, respectively. This eliminated nucleotides 6407–11,884 of
the RRV sequence and generated plasmids with a unique Sap I site just
20 bp upstream of the junction of the nsP1 and nsP2 coding regions.
Next, the BssH II–Sap I fragments were swapped between pRR90 and
pRR91 to create pRR92, which encodes RRV DC5692 strain sequence
fromBssH II–Sap I and T48 strain sequence from Sap I–Eag I, and pRR93,
which encodes T48 strain sequence fromBssH II–Sap I and RRVDC5692
strain sequence from Sap I–Eag I. Finally, the BssH II–Eag I fragment of
pRR92 and pRR93 was inserted in the BssH II–Eag I site of pRR64 to
create pRR94 and pRR95, respectively.
To generate plasmid pRR73, the RRV DC5692 Xma I–Hind III
fragmentwas inserted into the Xma I–Hind III site of pRR65 to generate
pRR71. The Hind III–Sac I fragment of pRR71was inserted into the Hind
III–Sac I site of pRR64 to generate pRR72. Finally, the RRV DC5692 Rsr
II–Xma I fragment was cloned into the Rsr II–Xma I site of pRR72 to
generate pRR73. Plasmid pRR78 was generated by inserting the RRV
DC5692 Xba I–Rsr II fragment into the Xba I–Rsr II site of pRR64. To
generate plasmids pRR100, pRR101, and pRR102, pRR64 and pRR73
were digestedwith Age I, to remove the Age I–Age I fragment, and then
religated at the Age I site to create pRR96 and pRR97, respectively. The
RRVDC5692 Age I–Rsr II fragmentwas inserted into the Age I–Rsr II site
of pRR96 and pRR97 to yield pRR98 and pRR99, respectively. Next, the
pRR64Age I–Age I fragmentwas inserted into theAge I siteofpRR98and
pRR99 to generate pRR100 and pRR101, respectively. The RRV DC5692
Age I–Age I fragment was inserted into pRR96 to yield pRR102.
Comparison of the RR64 and DC5692 genome sequences revealed
only 2 synonymous nucleotide differences within the ﬁrst 200
nucleotides of the nsP1 coding sequence of these two RRV strains.
Therefore, pRR87 encodes the entire coding region of RRV DC5692
except for the ﬁrst 193 nucleotides (nucleotides 272–11,329). To
generate pRR87, the RRV DC5692 BssH II–Xba I fragment was inserted
into pRR72 to create pRR82. Next, the RRV DC5692 Rsr II–Xma I
fragment was inserted into pRR78 to create pRR85. Finally, The Xba
I–Xma I fragment of pRR85was inserted into pRR82 to create pRR87. To
generate plasmid pRR106, pRR87 was digested with Eco RI and
the ~8300 bp fragment was gel isolated and religated to generate
pRR104. This eliminated nucleotides 6407–11,884 of the RRV sequence
and generated a plasmid with a unique Sap I site just 20 bp upstream of
the junction of the nsP1 and nsP2 coding regions. Next, the BssH II–Sap I
fragment from pRR64was cloned into pRR104 to create pRR105, which
encodes RRV T48 strain sequence from BssH II–Sap I and DC5692 strain
sequence from Sap I–Eag I. The BssH II–Xba I fragment of pRR105 was
inserted in the BssH II–Eag I site of pRR87 to create pRR106. To create
plasmid pRR108 and pRR109, the Age I–Xma I fragment from pRR102
was inserted into the Rsr II–Xma I site of pRR87 to create pRR107.
Finally, theXba I–Xma I fragment of pRR107was inserted into theXba I–
Xma I site of pRR87 or pRR106 to create pRR108 and pRR109,
respectively.
Cells
BHK-21 cells (ATCC CCL10) were grown in α-minimal essential
medium (Gibco) supplemented with 10% bovine calf serum (Hyclone),
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0.29 mg/ml L-glutamine. Vero cells (ATCC CCL81) were grown in
DMEM/F12 (Gibco) supplemented with 10% fetal bovine serum
(Lonza), non-essential amino acids (Gibco), sodium bicarbonate,
penicillin and streptomycin, and 0.29 mg/ml L-glutamine.
RNA infectivity assays
BHK-21 cells were plated at 5.0×104 cells/well in 12-well dishes.
Cells were transfected with 100 ng, 10 ng, 1 ng, and 0.1 ng of 5′-capped
full-length virus RNA transcripts using Lipofectamine 2000 according to
themanufacturer's instructions (Invitrogen). At 1.5 h post-transfection,
growth media was removed and cell monolayers were overlaid with
0.5% immunodiffusion agarose. Forty hours post-transfection, cellswere
stained with neutral red, plaques were enumerated, and the PFU per
microgram of RNA was determined.
Plaque assays
BHK-21 cells were seeded into 6 well dishes. Growth medium was
removed and cell monolayers were inoculated with serial 10-fold
dilutions of virus-containing samples. Following a 1-hour adsorption at
37 °C, cell monolayers were overlaid with 0.5% immunodiffusion agarose
(MP Biomedicals) inmedium for 38 to 40 h and then stainedwith neutral
red (Sigma). Plaque sizes were measured (n=25–30) and total plaques
were enumerated to determine the number of PFUpermilliliter of culture
supernatants and mouse serum or PFU per gram of tissue.
In vitro replication
Vero cells were plated at 105 cells/well in 24-well dishes. Growth
medium was removed, and wells were inoculated with virus in
triplicate at a multiplicity of infection of 0.01 pfu/cell. Viruses were
adsorbed to cells for 1 h at 37 °C. Wells were then washed three times
with 1 ml of room-temperature phosphate-buffered saline (PBS).
One milliliter of growth medium was then added to each well, and
cells were incubated at 37 °C. For cumulative growth analysis, 100 μl
samples of culture supernatants were removed at various times post-
inoculation and an equal volume of fresh medium was added to
maintain a constant volume within each well. Samples were frozen at
−80 °C until analysis by plaque assay on BHK-21 cells.
In vitro nonstructural protein processing
5′-Capped full-length RNA transcripts were generated in vitro
using SP6-speciﬁc mMessage mMachine in vitro transcription kits
(Ambion). 0.64 μg of each viral RNAwas added to a 100-μl reticulocyte
lysate reaction supplemented with [35S]-methionine (Heise et al.,
2003). Reaction mixtures were also supplemented with KCl to a ﬁnal
concentration of 0.05 M, and then incubated at 30 °C for 40 min, at
which point the chase was initiated by adding unlabeled methionine
to a ﬁnal concentration of 1 mM and cycloheximide at a ﬁnal concen-
tration of 0.6 mg/ml. Samples were then incubated at 37 °C for the
durationof the chase. Five-microliter sampleswere removedat0, 20, 40,
60, and 80 min into the chase and placed into 20 μl of gel loading buffer.
Sampleswereheatdenatured at 95 °C for 5 minand analyzedby sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (10%
polyacrylamide). Gels were analyzed on a phosphorimager.
Mouse experiments
C57BL/6J were obtained from The Jackson Laboratory (Bar Harbor,
Maine) and bred in house. Animal husbandry and experiments were
performed in accordance with all University of Colorado School of
Medicine Institutional Animal Care and Use Committee guidelines.
Although RRV is classiﬁed as a biosafety level 2 pathogen, due to itsexotic nature all mouse studies were performed in a biosafety level 3
laboratory. Twenty-four-day-oldmicewere used for all in vivo studies.
Mice were inoculated in the left rear footpad with 103 pfu of virus in
diluent (PBS/1% bovine calf serum) in a 10 μl volume. Mock-infected
animals received diluent alone. RRV inoculation resulted in 0%
mortality. Mice were monitored for disease signs and weighed at 24-
hour intervals. Disease scores were determined by assessing grip
strength, hind-limbweakness, and altered gait as previously described
using the following system: 1=verymild deﬁcit in hind paw gripping
ability of injected foot only; 2=very mild deﬁcit in bilateral hind paw
gripping ability; 3=bilateral loss of gripping ability, mild bilateral
hind-limb paresis; altered gait not readily observable; 4=Bilateral
loss of gripping ability, moderate bilateral hind-limb paresis, observ-
able altered gait; difﬁculty righting self; 5=bilateral loss of gripping
ability, severe bilateral hind-limb paresis, altered gait, unable to right
self; and 6=moribund. Consistent with previous studies which
indicated that there is little to no evidence of virus-induced pathology
in the central nervous system in this model, no RRV-inoculatedmouse
displayed evidence of paralysis, no mouse developed a disease score
N5, and no mouse was euthanized based on the criteria of weight loss
or a moribund state during the course of these studies.
To determine viral titers in tissues, mice were sacriﬁced by
exsanguinations, blood was collected, and mice were perfused by
intracardial injection of 1× PBS. The right and left ankles and right and
left quadriceps muscles were removed by dissection and weighed.
Tissues were homogenized in 1× PBS supplemented with 1% bovine
calf serum, Ca2+, andMg2+with aMagNA Lyser (Roche) and stored at
−80 °C until the amount of virus present was quantiﬁed by a standard
plaque assay on BHK-21 cells.
Histological analysis
At the times indicated, mice were sacriﬁced and perfused by
intracardial injection of 4% paraformaldehyde, pH 7.3. Tissues were
embedded in parafﬁn and 5-μm sections were prepared. To assess
histopathological changes such as tissue inﬂammation and damage,
tissue sections were stained with hematoxylin and eosin (H&E) and
evaluated by light microscopy.
Statistical analysis
Viral replication and tissue titers were evaluated for statistically
signiﬁcant differences using either the Student's t test or one-way
analysis of variance (ANOVA) followed by Dunn's multiple compar-
ison test. Disease scores were evaluated for statistically signiﬁcant
differences by repeated measures ANOVA followed by Bonferroni's
multiple comparison test.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2010.11.012.
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